Book Chapters and Reviews

Displaying 100 Publications
100

Antibiotic 9 Uptake

L Fernández, JB McPhee, S Tamber, MD Brazas, S Lewenza, REW Hancock
(2017), 1: 115 In Antimicrobial Drug Resistance: Mechanisms of Drug Resistance 1: 774 (Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim , eds.) Springer
99

Host Defense Peptides and Their Advancements in Translational Staphylococcus aureus Research.

Mansour S.C., R.E.W. Hancock, M. Otto In Host Defense Peptides and Their Potential as Therapeutic Agents. 1: 301-321 (Epand R.M. , eds.) Springer International Publishing.
98

High-Performance Liquid Chromatography and Mass Spectrometry-Based Design of Proteolytically Stable Antimicrobial Peptides.

Bagheri, M., Hancock, REW. (2016), In Antimicrobial Peptides: Methods and Protocols 61-71 (Hansen P.R. , eds.) Springer New York
97

Antimicrobial Peptides: An Introduction.

Haney, E., Mansour S., Hancock REW. (2016), In Antimicrobial Peptides: Methods and Protocols 3-22 (P.R. Hansen , eds.) Springer New York
96

Bioinformatics: Novel Insights from Genomic Information.

Hancock, R.E.W. (2016), In Next-Generation Nutritional Biomarkers to Guide Better Health Care. 84: 35-46 (Baetge E.E., Dhawan A., Prentice A.M. , eds.) Karger Publishers.
95

Antibiotic resistance due to reduced uptake.

Fernandez, L. J.B. McPhee, S. Tamber, S. Lewenza, M.D. Brazas, and R.E.W. Hancock. (2017), In Antimicrobial drug resistance: Principles and practice for the clinical bench. (D.L. Mayers , eds.) Humana Press, New Jersey.
94

High-performance liquid chromatography and mass spectrometry-based design of proteolytically stable antimicrobial peptides.

Bagheri, M., and R.E.W. Hancock. (2016), In Methods in Molecular Biology in: pres
93

Antimicrobial Peptides: An Introduction.

Haney, E.F., S.C. Mansour and R.E.W. Hancock. (2016), In Methods in Molecular Biology in: press
92

Host defense peptides and their advancements in translational Staphylococcus aureus research.

Mansour, S.C., R.E.W. Hancock and M. Otto. (2016), In Host defense peptides and their potential as therapeutic agents 301-321 (R. Epand , eds.) Elsevier
91

Polymyxin: alternative mechanisms of action and resistance.

Trimble, M.J., P. Mlynarcik, M. Kolar, and R.E.W. Hancock. (2016), In Cold Spring Harbor Perspectives in Medicine: 3;6(10):
90

Bioinformatics: Novel insights from genomic information.

Hancock, R.E.W. (2015), In Nestlé Nutrition Institute Workshop Series 84: 35-46
89

Using anti-biofilm peptides to treat antibiotic-resistant bacterial infections.

de la Fuente-Núñez, C., and R.E.W. Hancock (2015), In J. Postdoctoral Research 3(2): 1-8
88

Electrophoresis and Blotting of DNA.

Sedivy-Haley, K., S. Tamber, and R.E.W. Hancock (2013), In eLS 2013 John Wiley & Sons, Chichester
87

New strategies and compounds for anti-infective treatment.

Hancock R.E.W., and H.-G. Sahl. (2013), In Curr. Opin. Microbiol. 16: 519–521
86

Host defense peptides: Immune modulation and antimicrobial activity in vivo.

Afacan, N.J., L.M. Janot, and R.E.W. Hancock. (2013), In Antimicrobial peptides and innate immunity, Progress in Inflammation Research 321-358 (P.S. Hiemstra and S.A.J. Zaat , eds.) Springer Basel.
85

Host Defence (Antimicrobial) Peptides and Proteins.

Wuerth, Kelli C; Hilchie, Ashley L; Brown, Kelly L; and Hancock, REW (2013), In eLS 2013 77-84 John Wiley & Sons Ltd: Chichester
84

Cathelicidins.

Mookerhjee, N., K.L. Brown and R.E.W.Hancock. (2013), In Handbook of Biologically Active Peptides Ch. 15 (Kastan, A. ed.; Hancock, R.E.W. section ed , eds.) Elsevier
83

Immunomodulatory cationic peptide therapeutics: A new paradigm in infection and immunity.

Mookherjee, N., L. Chow and R.E.W. Hancock. (2012), In Small Wonders: Peptides for Disease Control. Ch. 1, pp. 1-19 (K. Rajasekaran, J.W. Cary, J.M. Jaynes, & E. Montesinos , eds.) ACS Books.
82

Pseudomonas aeruginosa: a persistent pathogen in cystic fibrosis and hospital-associated infections.

Schurek, K.N., E.B.M. Breidenstein and R.E.W. Hancock. (2012), In Antibiotic Drug Discovery and Development 679-715 (T.J. Dougherty and M.J. Pucci , eds.) Springer Publishing Company.
81

Importance of adaptive and stepwise changes in the rise and spread of antimicrobial resistance.

Fernández, L., E.B.M. Breidenstein, and R.E.W. Hancock. (2011), In Antimicrobial resistance in the environment. 43-71 (Keen P., Monforts M. , eds.) John Wiley and Sons.
80

Host Defense Peptides.

Pena, O.M., J.D.F. Hale, and R.E.W. Hancock. (2011), In Emerging Trends in Antibacterial Discovery – Answering the Call to Arms Ch 15. pp. 323-344. (AA. Miller and P.F. Miller , eds.) Calister Academic Press, Norfolk, UK.
79

Host defence (Antimicrobial) Peptides and Proteins.

Madera, L., S. Ma, and R.E.W. Hancock. (2010), In The Immune response to infection. 57-68. (Kaufmann, S.H.E., B. Rouse, and D. Sacks , eds.) ASM Press, Wasshington, DC.
78

Fine tuning host responses in the face of infection: Emerging roles and clinical applications of host defence peptides.

Mayer M.L., D.M. Easton, and R.E.W. Hancock. (2010), In Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies. Chapter 12, pp. 195-220 (G. Wang , eds.) CABI: Oxfordshire, UK.
77

Introduction to the Theme: Seeking Clarity for Membrane-active Peptides.

Hancock, R.E.W. (2010), In Membrane-active peptides: Methods and Results on Structure and Function. 3-9 (M. Castanho, , eds.) International University Line, La Jolla.
76

Systems-Level Analyses of the Mammalian Innate Immune Response.

Lynn D.J., J.L. Gardy, C.D. Fjell, R.E.W. Hancock, and F.S.L.Brinkman 2010 (2010), In Systems Biology for Signaling Networks 1 part 3: 531-560 Springer Publishing, N.Y.
75

Host defense peptides: Bridging antimicrobial and immunomodulatory activities

Kindrachuk, J., A. Nijnik, and R.E.W. Hancock. (2010), In Comprehensive Natural Products II Chemistry and Biology 5: 175-216 (Mander, L., Lui, H.-W , eds.) Elsevier: Oxford
74

Host Defense Peptides in Fish: From the Peculiar to the Mainstream, in Fish Defenses

Patrzykat, A., and R.E.W. Hancock (2009), In Pathogens, Parasites and Predators Vol 2.: 43-63 (G. Zaccone, C. Perrière, A. Mathis, and B.G. Kapoor , eds.) Science Publishers, New Hampshire.
73

Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides.

Jiang Z., A.I. Vasil, J. Hale, R.E.W. Hancock, M.L. Vasil, and R.S. Hodges. (2009), In Adv. Exp. Med. Biol. 611: 561-562
72

Synthesis of peptide arrays using SPOT-technology and the CelluSpots-method.

Winkler, D.F.H., K. Hilpert, O. Brandt and R.E.W. Hancock (2009), In Peptide Microarrays. Humana Press, New Jersey,
71

Antibiotic resistance due to reduced uptake.

McPhee, J.B., S. Tamber, S. Lewenza, M.D. Brazas, and R.E.W. Hancock. (2009), In Antimicrobial drug resistance: Principles and practice for the clinical bench 97-110 (D.L. Mayers, , eds.) Humana Press, New Jersey.
70

Antibacterial host defence peptides of bovine origin.

Jenssen H., K.Hilpert, and R.E.W. Hancock. (2007), In Chem. Today. 25: 17-19
69

Immunomodulatory properties of defensins and cathelicidins.

Bowdish, D.M.E., D.J. Davidson, and R.E.W. Hancock. (2006), In Curr. Top. Microbiol. Immunol. 306: 24-66
68

Cathelicidins: Cationic Host Defense and Antimicrobial Peptides.

Mookerhjee, N., K.L. Brown and R.E.W.Hancock. (2005), In Handbook of Biologically Active Peptides 55-66 (Kastan, A. ed.; Hancock, R.E.W. section ed , eds.)
67

Using the Pseudomonas aeruginosa genome to understand pathogenesis.

Hancock, R.E.W. (2004), In Ped. Pulmon. S27:142-143.
66

Porins of the outer membrane of Pseudomonas aeruginosa.

Hancock, R.E.W., and S. Tamber. (2004), In Bacterial and Eukaryotic Porins. Ch. 4, pp. 61-77 (Benz, R., , eds.) Wiley VCH Verlag, Weinheim.
65

Bacterial Structure and Physiology: Influence on Susceptibility to Cationic Antimicrobial Peptides.

Hancock, R.E.W. (2004), In Mammalian host defence peptides 226-244 (D.A. Devine and Hancock, R.E.W., , eds.) Cambridge University Press, NY.
64

“Antimicrobial” or “host defence” peptides?

Hancock, R.E.W., and D.A. Devine. (2004), In Mammalian host defence peptides. 1-4 (D.A. Devine and Hancock, R.E.W , eds.) Cambridge University Press, NY.
63

Mammalian host defence peptides.

Hancock, R.E.W., and D.A. Devine, (2004), In Advances in Molecular and Cellular Microbiology Series. Cambridge University Press, NY.
62

The Outer Membranes of Pseudomonads.

Tamber, S., and R.E.W. Hancock. (2004), In The Pseudomonads Vol I: 575-601 (J.L. Ramos, , eds.) Kluwer Academic, NY.
61

Bacterial biofilms of importance to medicine and bioterrorism: proteomic techniques to identify novel vaccine components and drug target.

Hassett, D.J., P.A. Limbach, R.F. Hennigan, K.E, Klose, R.E.W. Hancock, M.D.Platt, D.F. Hunt. (2003), In Exp. Opin. Biol. Ther. 3: 1201-1207
60

Electrophoresis and blotting of DNA

Tamber, S., and R.E.W. Hancock. (2003), In Nature Encyclopaedia of Life Sciences. London
59

Cationic peptides: Distribution and mechanisms of resistance.

Devine, D.A., and R.E.W.Hancock. (2002), In Curr. Pharmaceut. Design 8: 99-110
58

Cationic anti-microbial peptides.

Hancock, R.E.W. (2002), In Biochem. Cell Biol. 80: 140
57

Post-genomic Pseudomonas.

Lewenza, S., and R.E.W. Hancock. (2001), In Genome Biology 3: 4002.1-4002.2
56

Antimicrobial peptides for fish disease control.

Hancock, R.E.W., and A. Patrzykat. (2001), In Recent advances in marine biotechnology Vol. 7: Seafood Safety and Human Health Oxford and IBH Publishing Co., New Delhi.
55

Mechanism of action of imipenem and relevance of porin OprD.

Hancock, R.E.W. (2001), In Infections in Oncology 5: 2-3
54

Cationic antimicrobial peptide antibiotics.

Hancock, R.E.W., and P.Nair. (2000), In Curr. Opin. Antiinfective Invest. Drugs. 2: 140-148
53

Antibiotic resistance and survival in the host.

Macfarlane, E.L.A., and R.E.W. Hancock. (2000), In Virulence mechanisms of bacterial pathogens 3rd Edition: 93-104 (Brogden, K., J.A. Roth, T.B. Stanton, C.A. Bolin, F.C. Minion, and M.J. Wannemuehler, , eds.) ASM Press, Washington, DC.
52

Insect cationic antimicrobial peptides.

Hetru, C., J.A.Hoffmann, and R.E.W.Hancock. (2000), In Peptide antibiotics: Discovery, modes of action and applications. (Dutton, C., M.Haxell, H.I. McArthur, and R.Wax. Peptide , eds.) Marcel Dekker, New York.
51

Peptide antibiotics.

Zhang, L., and R.E.W.Hancock. (2000), In Antibiotic resistance and antibiotic development. 209-232 (Hughes, D., and Andersson, D.I., , eds.) Harwood Academic Publishers.
50

Cationic peptide antibiotics for use in treatment of Pseudomonas aeruginosa infections of cystic fibrosis patients.

Hancock, R.E.W., M. Scott, C.Friedrich, L.Zhang, H.Yan, P.Nair, A.Patrzykat, and A.Rozek. (1999), In Clin. Microbiol. Infect 5: S52-S53.
49

Cationic peptide antibiotics: a diversified portfolio for the future.

Hancock, R.E.W., and A.Patrzykat (1999), In Chimica Oggi (Biocides Today supplement) 20-21
48

Host defence (cationic) peptides: What is their future clinical potential?

Hancock, R.E.W. (1999), In Drugs 57: 469-473
47

Anti-microbial activities of phytochemicals from British Columbian medicinal plants.

Towers, G.H.N., McCutcheon, A., Saxena, G., Matsuura, H., Page, J., Farmers, S., Gibbons, E. Roberts, T.E., Babiuk, L.A., Thorson, I.M., Stokes, R.W., Sokol, P., Klingemann, H., and Hancock, R.E.W. (1999), In Chemistry, Biological, and Pharmacological Properties of Medicinal Plants from the Americas. 125-142 (Hostettmann, K., Gupta, M.P., and Marston, A. , eds.) Harwood Academic Publ. Switzerland.
46

Are we approaching the end of the antibiotic era? Editorial overview.

Hancock, R.E.W., and D.Knowles. (1998), In Curr. Opinion Microbiol. 1: 493-494
45

Pseudomonas aeruginosa: Infection and Immunity.

Hancock, R.E.W. and J.S. Lam (1998), In Encyclopaedia of Immunology 2nd Edition 4: 2042-2045 (P.J.Delves , eds.) Academic Press, London.
44

Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria.

Hancock, R.E.W. (1998), In Clin. Infect. Dis 27: S93-99
43

Outer membrane proteins

Hancock, R.E.W., and E.A. Worobec. (1998), In Biotechnology Handbooks. 10 Pseudomonas, : 139-167 (Montie T., , eds.) Plenum Press, London.
42

The role of fundamental research and biotechnology in finding solutions to the global problem of antibiotic resistance.

Hancock, R.E.W. (1997), In Clin. Infect. Dis. 24 (Supplement 1): S148-S150
41

Potential of protein OprF of Pseudomonas in bivalent vaccines.

Hancock, R.E.W. and R. Wong. (1997), In Behring Institute Mitteilungen 98: 283-290 (Domdey, H., W. Lubitz, F. Schodel and B. von Specht , eds.) DMV, Marburg.
40

Isolation and characterization of porins from H. pylori.

Hancock, R.E.W. and M. Exner. (1997), In Methods Molec. Med. Helicobacter pylori protocols. 191-204 (Clayton, C.L. and H.L.T. Mobley , eds.) Humana Press In., Totowa, N.J.
39

Antibiotics for Pseudomonas and related infections.

Hancock, R.E.W., and D.P. Speert. (1996), In Cystic Fibrosis - current topics ( 3: 245-266 (Dodge, J.A., Brock, D.J.H., and Widdicombe, J.H., , eds.) John Wiley and Sons Ltd.
38

Cationic peptides: a class of antibiotics able to access the self promoted uptake pathway across the outer membrane of Pseudomonas aeruginosa.

Hancock, R.E.W., K. Piers, M. Brown, T. Falla, M. Gough, M. Wu and S. Fidai. (1996), In Molecular Biology of Pseudomonads. (Nakazawa, T., Furukawa, K., Haas, D., and Silver, S., , eds.) ASM Press, Washington.
37

Cationic Peptides

Hancock, R.E.W., and T. Falla, (1996), In Biotechnology of Antibiotics 2: Ch 16. 467-492 (Strohl, W.R., , eds.) Marcell Dekker Inc., N.Y.
36

Small Peptide Antibiotics.

Hancock, R.E.W., S. Fidai, M. Gough, M. Wu, and K. Piers. (1994), In Pediatric Pulmonology 10(S): 161-162
35

Bacterial transport as an import mechanism and target for antimicrobials.

Hancock, R.E.W. (1994), In Drug transport in antimicrobial and anticancer chemotherapy 293-306 (Georgopapadakou, N. , eds.) Marcel Dekker, Inc., New York.
34

Cationic Bactericidal peptides

Hancock, R.E.W., T. Falla and M.H. Brown (1995), In Adv. Microb. Physiol. 37: 135-175
33

Canadian Bacterial Diseases Network: a new approach to University-Industry relationships.

Hancock, R.E.W. and T.E. McCurry. (1993), In Clin. Invest. Med. 16: 306-313
32

Cloning of outer membrane protein genes and molecular genetic methods for studying structure function relationships.

Siehnel, R.J., R.S.Y. Wong, H. Huang and R.E.W. Hancock (1994), In Meth. Molec. Genet. 3: 311-324
31

Outer membrane proteins.

Hancock, R.E.W., and K. Piers. (1994), In Escherichia coli in animals. 495-532 (Gyles C.L , eds.) International, Wallingford, U.K.
30

Molecular organization and structural role of outer membrane macromolecules.

Hancock, R.E.W., C. Egli and N. Karunaratne. (1994), In Bacterial Cell Envelope 263-279 (J.M. Ghuysen and Hakenbeck, R., , eds.) Elsevier Science Publishers BV, Amsterdam.
29

Susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents.

Bellido, F., and R.E.W.Hancock. (1994), In Pseudomonas aeruginosa as an opportunistic pathogen. 321-348 (Campa, M., M. Bendinelli, and H.Friedman, , eds.) Plenum Press, NY.
28

Bacterial Porins.

Hancock, R.E.W. and M.H. Brown. (1992), In Today's Life Science 4: 24-32
27

Function and structure of Pseudomonas aeruginosa outer membrane protein OprF.

Bellido, F., R.L. Finnen, N.L. Martin, R.J. Siehnel and R.E.W. Hancock. (1992), In Pseudomonas: Molecular Biology and Biotechnology. 170-176 (Galli, E., S. Silver and B. Witholt , eds.) American Society for Microbiology, Washington, D.C.
26

Bacterial outer membranes: Evolving Concepts.

Hancock, R.E.W. (1991), In ASM News 57: 175-182
25

LPS integration into outer membrane structures.

Hancock, R.E.W. and N. Karunaratne. (1990), In Cellular and Molecular Aspects of Endotoxin Reactions. I: 191-196 (Nowotny, A., Spitzer, J.J., and Ziegler, E.J., , eds.) Elsevier Science Publishers B.V., Amsterdam.
24

Function and structure of the porin proteins OprF and OprP of Pseudomonas aeruginosa.

Siehnel, R.J., N.L. Martin and R.E.W. Hancock. (1990), In Pseudomonas: Biotransformations, pathogenesis and evolving biotechnology. 328-342 (Silver, S., A.M. Chakrabarty, B. Iglewski, and S. Kaplan , eds.) American Society for Microbiology, Washington.
23

Function and structure of the major components of the outer membrane of gram-negative bacteria.

Martin, N.L. and R.E.W. Hancock. (1990), In Advances in Brucellosis Research 55-75 (L.G. Adams , eds.) Texas A & M University Press, College Station.
22

Antibiotic uptake into Gram negative bacteria.

Hancock, R.E.W. and A. Bell. (1989), In Perspectives in anti-infective therapy 21-28 (G.G. Jackson, H.D. Schlumberger, and H.J. Zeiler, , eds.) Vieweg and Sohn, Braungshweig.
21

Roles of porin and β-lactamase in β-lactam resistance of Pseudomonas aeruginosa.

Hancock, R.E.W. and W.A. Woodruff. (1988), In Rev. Infect. Dis. 10: 770-775
20

Role of outer membrane components in Pseudomonas aeruginosa colonization of the cystic fibrosis lung.

Hancock, R.E.W. and N. Kelly. (1987), In Pediatr. Pulmon., Suppl. 1: 89-91
19

Antibiotic uptake pathways across the outer membrane of Pseudomonas aeruginosa.

Moore, R.A., W.A. Woodruff and R.E.W. Hancock. (1987), In . Antibiotics and Chemotherapy 39: 172-181
18

Phosphate-binding site of Pseudomonas aeruginosa outer membrane protein P.

Hancock, R.E.W., E.A. Worobec, K. Poole and R. Benz. (1987), In Phosphate metabolism and cellular regulation in microorganisms 176-180 (Torriani, A., Silver, S., Rathman, F., Wright, A., and Yagel, E., , eds.) ASM, Washington.
17

Model membrane studies of porin function.

Hancock, R.E.W. (1987), In Bacterial Outer Membranes as Model Systems 187-226 (Inouye, M., , eds.) John Wiley and Sons, New York.
16

The penetration of antibiotics into the antibiotic resistant bacterium seudomonas aeruginosa: Interaction of polycationic antibiotics at a common site on the lipopolysaccharide.

Moore, R.A. and R.E.W. Hancock (1985), In Chemioterapia 4 Suppl. No. 2: 3-5
15

The outer membrane proteins of Pseudomonas aeruginosa: Immunotherapeutic potential.

Hancock, R.E.W., E.C.A. Mouat, S.L. Butters and D.P. Speert. (1986), In Seminars in Infectious Diseases. (Robbins, J.B., , eds.)
14

Outer membrane permeability of Pseudomonas aeruginosa.

Nikaido, H. and R.E.W. Hancock (1986), In The Bacteria: A treatise on structure and function. X: 145-193 (Sokatch, J.R., , eds.) Academic Press, London.
13

Monoclonal Antibodies against bacterial outer membrane antigens.

Hancock, R.E.W. and L.M. Mutharia. (1985), In Advances in Experimental Medicine and Biology 185: 215-222 (Atassi, M. and H.L. Bachrach , eds.) Plenum Press Inc., New York.
12

The Pseudomonas aeruginosa outer membrane permeability barrier and how to overcome it.

Hancock, R.E.W. (1985), In Antibiotics and Chemotherapy 95-102 (Speert, D.P., and R.E.W. Hancock , eds.) S. Karger, Basel.
11

Laboratory characterization of lipopolysaccharides (LPS).

Hancock, R.E.W. (1985), In Bayer Symposium VII: Pathogenesis of Bacterial Infections. 398 (G.G. Jackson and J. Thomas, , eds.) Springer-Verlag, Berlin.
10

Monoclonal antibody protection against Pseudomonas aeruginosa.

Hancock, R.E.W. (1985), In Bayer Symposium VII: Pathogenesis of Bacterial Infections. 422-424 (G.G. Jackson and J. Thomas, , eds.) Springer-Verlag, Berlin.
9

The role of the cell surface components of Pseudomonas aeruginosa in virulence.

Hancock, R.E.W. (1985), In Bayer Symposium VII: Pathogenesis of Bacterial Infections. 247-256 (G.G. Jackson and J. Thomas, , eds.) Springer-Verlag, Berlin.
8

Application of monoclonal antibodies to the study of the surface antigens in Pseudomonas aeruginosa.

Lam, J.S.L., L.M. Mutharia and R.E.W. Hancock. (1985), In Monoclonal antibodies against bacteria II: 143-157 (A.J.L. Macario and E.C. Macario, , eds.) Academic Press, New York.
7

Use of monoclonal antibodies in the study of common antigens in gram negative bacteria.

Mutharia, L.M., J.S.L. Lam and R.E.W. Hancock. (1985), In Monoclonal antibodies against bacteria 131-142 (A.J.L. Macario and E.C. de Macario, , eds.) Academic Press, New York.
6

Ionic channels in membranes.

Benz, R., K. Poole and R.E.W. Hancock. (1984), In Biophysical Discussions 81-82 (Parsegian, V.A., , eds.) Rockefeller University Press, New York.
5

Resistance to antibacterial agents acting on cell membranes.

Hancock, R.E.W. and T.I. Nicas. (1984), In Antimicrobial Drug Resistance 147-171 (Bryan, L.E., , eds.) Academic Press, New York.
4

Molecular Interactions of aminoglycosides with bacteria - Implications for therapy.

Hancock, R.E.W., B. Loh and T.I. Nicas. (1983), Proc. 13th International Congress of Chemotherapy 35: 1-3
3

Aminoglycoside uptake and mode of action - with special reference to streptomycin and gentamicin. I. Antagonists and mutants.

Hancock, R.E.W. (1981), J. Antimicrob. Chemother. 8: 249-276.
2

Functional organization of the outer membrane of Escherichia coli: Phage and colicin receptors as components of iron uptake systems.

Braun, V., R.E.W. Hancock, K. Hantke and A. Hartman. (1976), In Progress in Clinical and Biological Research 17: 11-32 (Revel, J.P., U. Henning and C.F. Fox , eds.) Alan R. Liss Inc., New York.
1

A mutation in Escherichia coli K-12 affecting conjugation, phage resistance and a major membrane protein

Hancock, R.E.W., R.A. Skurray and P. Reeves. (1975), Proc. Aust. Biochem. Soc. 7: 80